Philip Ginsburg, MD
Gastroenterology · Rutland, VTNPI 1679554539
Payments from drug & device makers
Across 1,207 payments — averaging $2407.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1.4M
- Pfizer$367K
- Takeda Pharmaceuticals U.S.A., Inc.$251K
- Janssen Research & Development, LLC$188K
- Johnson & Johnson$146K
- Eli Lilly$116K
- plus $452K from 20 others
Across 6 payments — averaging $1392.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$8K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 685 | $1,388,047 |
| Pfizer | 89 | $366,562 |
| Takeda Pharmaceuticals U.S.A., Inc. | 84 | $250,773 |
| Janssen Research & Development, LLC | 88 | $187,824 |
| Johnson & Johnson | 104 | $145,536 |
| Eli Lilly | 21 | $115,670 |
| Genentech, Inc. | 13 | $91,918 |
| E.r. Squibb & Sons, L.L.C. | 26 | $75,058 |
| UCB Biosciences Inc. | 3 | $64,155 |
| Boehringer Ingelheim | 5 | $59,665 |
| F. Hoffmann-la Roche AG | 2 | $47,810 |
| Amgen | 7 | $36,743 |
| Lilly USA, LLC | 25 | $22,977 |
| Boehringer Ingelheim International GmbH | 3 | $20,690 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 7 | $19,337 |
| Hoffmann-la Roche Limited | 3 | $7,766 |
| Bristol Myers Squibb | 11 | $2,462 |
| Boehringer Ingelheim RCV GmbH & Co KG | 12 | $1,477 |
| Redhill Biopharma Inc. | 1 | $837 |
| Fresenius Kabi USA, LLC | 2 | $633 |
| Pentax Of America, Inc. | 9 | $132 |
| Medtronic | 1 | $69 |
| Digestive Care, Inc. | 2 | $54 |
| Aimmune Therapeutics, Inc. | 2 | $44 |
| Shionogi Inc | 1 | $16 |
| Gilead | 1 | $15 |
How this compares
$2,906,270 in reported general payments places this provider in the 95th percentile of 25 gastroenterology providers in Vermont.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Rutland
- Joseph WilliamsRutland$0
- Michael GleesonRutland$0
- Heiko PohlWhite River Junction$237K
- Eric GangulyBurlington$43K
- Jason HeffleyBurlington$28K
- Peter MosesBurlington$8K
- Cory HalliburtonColchester$7K
- David SchwartzColchester$3K
- David FurmanBennington$3K
- Michael UzerBurlington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.